NCT06625736Completed
Anti-obesity Effects of Dandelion (Taraxacum Officinale L.)
Anti-obesity Effects of Dandelion (Taraxacum Officinale L.) in Premenopausal Obese Women: Impacts on Appetite, Energy Intake and Lipid Metabolism
Source: ClinicalTrials.gov · Last updated 3 Oct 2024
Brief summary (registry, in English)
The study investigates the effectiveness of the natural product Dandelion in treating obesity in premenopausal women through a randomized interventional trial, measuring various parameters and biomarkers.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 120 (actual)
- First submitted
- 30 Sept 2024
- Start date
- 5 Jan 2024
- Primary completion date
- 7 Sept 2024
- Lead sponsor
- October 6 University
- Diseases
- Obesity
- NCT number
- NCT06625736
What you commit to
- Study type: Interventional
- Participants enrolled: 120
- From 5 Jan 2024 to the primary completion date, 7 Sept 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Pregnancy Breastfeeding Diabetes Cardiovascular diseases kidney or liver diseases use of medications that affect body weight Smoking Allergy to dandelion or related plants
Who the study is looking for
- Premenopausal women with obesity. Age between 18-45 years Stable body weight in the past 3 months
Age in the registry: 18 years to 45 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| October 6 University Hospital Coordinator of this site? Confirm its status | Giza | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.